DYRK1A and cancer: In quiescence, the DYRK1A protein kinase is activated, DYRK1A phosphorylates cyclin D (promotes proliferation) and p27 (inhibits proliferation)—among other targets—degrading the former and stabilizing the latter, which contributes to cancer dormancy [31,32].